Abstract

Background A growing number of adults are receiving pharmacological treatment for ADHD but a sizable proportion also discontinues or have gaps in treatment. The primary aims of this study were to identify how many patients treated for ADHD in adulthood, have at least one event of discontinuation in treatment and to identify possible associated variables. Methods Within the Danish population aged 18–60 years on the 1st of January 2013, we identified the number of individuals who had been prescribed ADHD-medication at least once during the 1st of January 2002–31st of December 2013 using Danish register data. Among those who filed more than one prescription, treatment discontinuation was defined as having more than 211 days between two prescriptions. In crude and adjusted logistic regression analysis, we explored potential associations to discontinuation for variables such as gender and age at treatment initiation. Results In a population, if N = 3,165,844 individuals, n = 42,892 had received at least one prescription for ADHD medication. Among those with more than one prescription (N = 38,289), 29.4% had discontinued their treatment at least once, according to our definition of treatment discontinuation. ADHD treatment discontinuation was associated with being male, unemployment, lower educational attainment, receiving incapacity benefits and younger age at treatment initiation (p < 0.001). Conclusions A large proportion of individuals treated for ADHD had at least one discontinuation of treatment according to our definition. Although the present study does not allow for investigating the direction of these effects, nor whether some patients later resumed treatment, having at least one discontinuation was associated with a range of variables relating to e.g. age and gender, and provides an emerging profile for clinicians of patients more likely to discontinue.

Highlights

  • Attention Deficit Hyperactivity Disorder (ADHD) is a chronic condition that often continues into adulthood (Caye et al, 2016), and is associated with an increased risk of for instance developing substance use problems, anxiety disorder, affective disorders (Chang et al 2016)

  • ADHD treatment discontinuation was associated with being male, unemployment, lower educational attainment, receiving incapacity benefits and younger age at treatment initiation (p

  • A large proportion of individuals treated for ADHD had at least one discontinuation of treatment according to our definition

Read more

Summary

Introduction

Attention Deficit Hyperactivity Disorder (ADHD) is a chronic condition that often continues into adulthood (Caye et al, 2016), and is associated with an increased risk of for instance developing substance use problems, anxiety disorder, affective disorders (Chang et al 2016). The prevalence of ADHD in adulthood has been estimated at 2.5% (Simon, Czobor, Bálint, Mészáros, & Bitter, 2009) Both stimulant and non-stimulant medication have been found to be effective in reducing core symptoms and some impairments in adults (Cortese et al, 2018; Cunill, Castells, Tobias, & Capellà, 2016) and are recommended in clinical guidelines (NICE, 2018). Despite the effectiveness of ADHD medications in the short term (Caye, Swanson, Coghill, & Rohde, 2019) treatment discontinuation is common (Gajria et al, 2014). The primary aims of this study were to identify how many patients treated for ADHD in adulthood, have at least one event of discontinuation in treatment and to identify possible associated variables

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call